Zobrazeno 1 - 2
of 2
pro vyhledávání: '"C. K. Inzan"'
Autor:
C. K. Inzan, C. Raharisolo, Philippe Esterre, E. Randrianiaina, A. Andriantsimahavandy, P. Roig, M. Ratsioharana
Publikováno v:
Journal of Dermatological Treatment. 9:S29-S34
A multicentre, pilot clinical trial of terbinafine was performed on 35 patients with active chromoblastomycosis to evaluate its potential as a novel therapy for this fungal disorder. The clinical results were excellent. In patients infected with Fons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4000efb962a12e05dcc491f0ace294c2
https://doi.org/10.3109/09546639809160714
https://doi.org/10.3109/09546639809160714
Autor:
J.L. Pecarrere, E.R. Ramarcel, C. K. Inzan, Philippe Esterre, A. Andriantsimahavandy, P. Roig, M. Ratsioharana
Publikováno v:
The British journal of dermatology. 134
In an open trial, long courses (6-12 months) of terbinafine at a dosage of 500 mg/day were administered orally to 43 patients with a diagnosis of chromomycosis. Sixteen patients (37.2%) had previously relapsed after one or two courses of thiabendazol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e6dfb336f994349a9022d8cd848153
https://pubmed.ncbi.nlm.nih.gov/8763467
https://pubmed.ncbi.nlm.nih.gov/8763467